The global malignant pleural effusion market will likely reach a valuation of USD 8.06 billion by 2033, rising from USD 4.5 billion in 2023. The market is slated to grow at a positive CAGR of 6% from ...

This in silico study presents the use of a virtual patient to investigate the impact of large pleural effusion (PE) and therapeutic thoracentesis (TT) on hemidiaphragm function and arterial blood ...

1 Department of Pulmonay and Critical Care Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 2 School of Clinical Medicine, Shanghai University of Medicine ...

TAP-IT (Thoracentesis to Alleviate Cardiac Pleural Effusion–Interventional Trial) investigated the effect of therapeutic thoracentesis in addition to standard medical therapy in patients with acute ...